Altimmune

Youtube Subscribe

Open: 2.68 Close: 2.81 Change: 0.13

The top 11 things about Altimmune found by an AI.

The game is changing. There is a new strategy to evaluate Altimmune fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Altimmune are: Altimmune, Inc, develop, change, Get, Free, FLUX, and the …

Concept Map

Semantic Network

Stock Summary

Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is in Phase 2 trial for obesity. It is also developing HepTcell, an immunother.

Today's Summary

Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. State Street Corp lifted its stake in shares of Altimmune by 2,407.5% in the 3rd quarter. The average price target for Altimmune, Inc. is 18.50 - 572.73% Upside.

Today's News

Altimmune Inc. is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. Try It for Just $1 Be the first to know about important DNLI news, forecast changes, insider trades & much more! Get Free FLUX Updates FLUX News and more! Altimmune ( NASDAQ:ALT – Get Free Report ) last announced its quarterly earnings data on Thursday, August 10th. Hedge funds have recently made changes to their positions in ALT. State Street Corp lifted its stake in shares of Altimmune by 2,407.5% in the 3rd quarter. Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation therapeutics for the treatment of obesity and liver diseases. The average price target for Altimmune, Inc. is 18.50 - 572.73% Upside to $35.00 $6.00.

Stock Profile

"Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland."

Keywords

Are looking for the most relevant information about Altimmune? Investor spend a lot of time searching for information to make investment decisions in Altimmune. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Altimmune are: Altimmune, Inc, develop, change, Get, Free, FLUX, and the most common words in the summary are: inc, altimmune, company, pharmaceutical, therapeutic, view, market, . One of the sentences in the summary was: Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #inc #altimmune #company #pharmaceutical #therapeutic #view #market.

Read more →

Youtube Subscribe

---